217 related articles for article (PubMed ID: 36160835)
1. Advanced magnetic resonance imaging findings in salivary gland tumors.
Gökçe E; Beyhan M
World J Radiol; 2022 Aug; 14(8):256-271. PubMed ID: 36160835
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic efficacy of diffusion-weighted imaging and semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging in salivary gland tumors.
Gökçe E; Beyhan M
World J Radiol; 2023 Jan; 15(1):20-31. PubMed ID: 36721673
[TBL] [Abstract][Full Text] [Related]
3. Characterization of parotid gland tumors: added value of permeability MR imaging to DWI and DCE-MRI.
Yabuuchi H; Kamitani T; Sagiyama K; Yamasaki Y; Hida T; Matsuura Y; Hino T; Murayama Y; Yasumatsu R; Yamamoto H
Eur Radiol; 2020 Dec; 30(12):6402-6412. PubMed ID: 32613285
[TBL] [Abstract][Full Text] [Related]
4. Parotid gland tumors: comparison of conventional and diffusion-weighted MRI findings with histopathological results.
Karaman CZ; Tanyeri A; Özgür R; Öztürk VS
Dentomaxillofac Radiol; 2021 May; 50(4):20200391. PubMed ID: 33237812
[TBL] [Abstract][Full Text] [Related]
5. Imaging biomarkers in the diagnosis of salivary gland tumors: the value of lesion/parenchyma ratio of perfusion-MR pharmacokinetic parameters.
Mungai F; Verrone GB; Bonasera L; Bicci E; Pietragalla M; Nardi C; Berti V; Mazzoni LN; Miele V
Radiol Med; 2021 Oct; 126(10):1345-1355. PubMed ID: 34181206
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of various salivary gland tumours using diffusion-weighted MRI and dynamic contrast-enhanced MRI.
Kushwaha M; Kumar J; Garg A; Singh I; Khurana N
Pol J Radiol; 2023; 88():e203-e215. PubMed ID: 37234459
[TBL] [Abstract][Full Text] [Related]
7. Quantitative dynamic contrast-enhanced MRI and readout segmentation of long variable echo-trains diffusion-weighted imaging in differentiating parotid gland tumors.
Huang N; Xiao Z; Chen Y; She D; Guo W; Yang X; Chen Q; Cao D; Chen T
Neuroradiology; 2021 Oct; 63(10):1709-1719. PubMed ID: 34241661
[TBL] [Abstract][Full Text] [Related]
8. Diffusion kurtosis imaging and dynamic contrast-enhanced MRI for the differentiation of parotid gland tumors.
Huang N; Chen Y; She D; Xing Z; Chen T; Cao D
Eur Radiol; 2022 Apr; 32(4):2748-2759. PubMed ID: 34642805
[TBL] [Abstract][Full Text] [Related]
9. Perfusion imaging of parotid gland tumours: usefulness of arterial spin labeling for differentiating Warthin's tumours.
Kato H; Kanematsu M; Watanabe H; Kajita K; Mizuta K; Aoki M; Okuaki T
Eur Radiol; 2015 Nov; 25(11):3247-54. PubMed ID: 25921591
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging of salivary gland tumours: Key findings for imaging characterisation.
Maraghelli D; Pietragalla M; Cordopatri C; Nardi C; Peired AJ; Maggiore G; Colagrande S
Eur J Radiol; 2021 Jun; 139():109716. PubMed ID: 33866123
[TBL] [Abstract][Full Text] [Related]
11. Interest of diffusion-weighted and gadolinium-enhanced dynamic MR sequences for the diagnosis of parotid gland tumors.
Lechner Goyault J; Riehm S; Neuville A; Gentine A; Veillon F
J Neuroradiol; 2011 May; 38(2):77-89. PubMed ID: 20542568
[TBL] [Abstract][Full Text] [Related]
12. Dynamic Contrast Magnetic Resonance Imaging (DCE-MRI) and Diffusion Weighted MR Imaging (DWI) for Differentiation between Benign and Malignant Salivary Gland Tumors.
Assili S; Fathi Kazerooni A; Aghaghazvini L; Saligheh Rad HR; Pirayesh Islamian J
J Biomed Phys Eng; 2015 Dec; 5(4):157-68. PubMed ID: 26688794
[TBL] [Abstract][Full Text] [Related]
13. Differential diagnosis of parotid gland tumours: Application of SWI combined with DWI and DCE-MRI.
Xu Z; Chen M; Zheng S; Chen S; Xiao J; Hu Z; Lu L; Yang Z; Lin D
Eur J Radiol; 2022 Jan; 146():110094. PubMed ID: 34906852
[TBL] [Abstract][Full Text] [Related]
14. Epidemiological Profile of Salivary Gland Tumors in Southern Iranian Population: A Retrospective Study of 405 Cases.
Ghaderi H; Kruger E; Ahmadvand S; Mohammadi Y; Khademi B; Ghaderi A
J Cancer Epidemiol; 2023; 2023():8844535. PubMed ID: 38026266
[TBL] [Abstract][Full Text] [Related]
15. Salivary Gland Tumors: A Clinicopathologic Analysis From Taipei Veterans General Hospital.
Liao WC; Chih-Chao C; Ma H; Hsu CY
Ann Plast Surg; 2020 Jan; 84(1S Suppl 1):S26-S33. PubMed ID: 31833885
[TBL] [Abstract][Full Text] [Related]
16. Multiparametric magnetic resonance imaging of parotid tumors: A systematic review.
Coudert H; Mirafzal S; Dissard A; Boyer L; Montoriol PF
Diagn Interv Imaging; 2021 Mar; 102(3):121-130. PubMed ID: 32943368
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of combined quantitative diffusion-weighted MRI and routine contrast-enhanced MRI in discrimination of benign and malignant salivary gland tumors.
Nada A; Hady D; Youssef A; Mahmoud E; Assad RE
Neuroradiol J; 2020 Jun; 33(3):216-223. PubMed ID: 32223516
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of pleomorphic adenoma and Warthin's tumor of the parotid gland: ultrasonographic features.
Rong X; Zhu Q; Ji H; Li J; Huang H
Acta Radiol; 2014 Dec; 55(10):1203-9. PubMed ID: 24324278
[TBL] [Abstract][Full Text] [Related]
19. T2 mapping and readout segmentation of long variable echo-train diffusion-weighted imaging for the differentiation of parotid gland tumors.
Baohong W; Jing Z; Zanxia Z; Kun F; Liang L; Eryuan G; Yong Z; Fei H; Jingliang C; Jinxia Z
Eur J Radiol; 2022 Jun; 151():110265. PubMed ID: 35472650
[TBL] [Abstract][Full Text] [Related]
20. Radiomics Analysis in Characterization of Salivary Gland Tumors on MRI: A Systematic Review.
Mao K; Wong LM; Zhang R; So TY; Shan Z; Hung KF; Ai QYH
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
